Treatment of advanced or metastatic triple negative breast cancer with tumor infiltrating lymphocytes (TILs).

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-511915-21-01

Acronym

The TILS001 trial

Enrollment

Registered

2024-06-20

Start date

2025-05-05

Completion date

Unknown

Last updated

2025-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

advanced or metastasic triple-negative breast cancer

None listed

Sex/Gender

All

Age

18 Years to No maximum

Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026